Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.251
Neutral
RSI(14)
52.568
Neutral
STOCH(KDJ)(9,3,3)
52.507
Neutral
ATR(14)
0.275
Low Volatility
CCI(14)
-92.874
Neutral
Williams %R
39.936
Buy
TRIX(12,20)
0.597
Sell
StochRSI(14)
92.181
Buy
RDGT
RDGT3.570USD
+0.010+0.28%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
20.90MMarket Cap
1.94P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of RDGT
Currency: USD Updated: 2025-12-19Key Insights
Ridgetech Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 28/31 in the Food & Drug Retailing industry.Institutional ownership is high.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
RDGT's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
RDGT Highlights
StrengthsRisks
Ridgetech Inc, formerly China Jo-Jo Drugstores Inc, is a retailer and distributor of pharmaceutical and other healthcare products. The Company operates in four business segments. The Retail Drugstores segment sells prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment sells OTC drugs, dietary supplements, medical devices and sundry items through its own and third-party platforms. The Wholesale Business segment includes supplying the Company's own retail drugstores and selling them to other drug vendors and hospitals. The Farming and Selling Herbs segment cultivates selected herbs for sales to other drug vendors.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Fairly Valued
The company’s latest PE is 2.04, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 46.41K shares, decreasing 27.18% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Financial Health
Currency: USD Updated: 2025-12-19The current financial score of Ridgetech Inc is 7.12, ranking 19/31 in the Food & Drug Retailing industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 71.16M, representing a year-over-year decrease of 9.44%, while its net profit experienced a year-over-year decrease of 146.37%.
Score
Financials
7.10
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
2.79
Operational Efficiency
9.46
Growth Potential
8.78
Shareholder Returns
7.48
RDGT's Company Valuation
Currency: USD Updated: 2025-12-19The current valuation score of Ridgetech Inc is 8.22, ranking 11/31 in the Food & Drug Retailing industry. Its current P/E ratio is 2.04, which is 4196.36% below the recent high of 87.60 and 100.00% above the recent low of 0.00.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 28/31
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-19No earnings forecast score is currently available for Ridgetech Inc. The Food & Drug Retailing industry's average is 7.62.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
No Data
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-19The current price momentum score of Ridgetech Inc is 3.61, ranking 30/31 in the Food & Drug Retailing industry. Currently, the stock price is trading between the resistance level at 4.56 and the support level at 3.08, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
3.653
Sell
MA10
3.814
Sell
MA20
3.959
Sell
MA50
3.008
Buy
MA100
2.143
Buy
MA200
1.601
Buy
Institutional Confidence
Currency: USD Updated: 2025-12-19The current institutional shareholding score of Ridgetech Inc is 3.00, ranking 17/31 in the Food & Drug Retailing industry. The latest institutional shareholding proportion is 0.79%, representing a quarter-over-quarter decrease of 97.89%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 1.00% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2025-12-19The current risk assessment score of Ridgetech Inc is 1.48, ranking 27/31 in the Food & Drug Retailing industry. The company's beta value is -0.31. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
-0.31
VaR
+9.24%
240-Day Maximum Drawdown
+100.00%
240-Day Volatility
--
Return
Best Daily Return
60 days
+73.81%
120 days
--
5 years
--
Worst Daily Return
60 days
-18.48%
120 days
-100.00%
5 years
-100.00%
Sharpe Ratio
60 days
+2.92
120 days
--
5 years
--
Risk Assessment
Maximum Drawdown
240 days
+100.00%
3 years
+100.00%
5 years
+100.00%
Return-to-Drawdown Ratio
240 days
+0.69
3 years
-0.32
5 years
-0.20
Skewness
240 days
--
3 years
--
5 years
--
Volatility
Realised Volatility
240 days
--
5 years
--
Standardised True Range
240 days
+4.93%
5 years
+119.39%
Downside Risk-Adjusted Return
120 days
--
240 days
--
Maximum Daily Upside Volatility
60 days
+202.89%
Maximum Daily Downside Volatility
60 days
+81.00%
Liquidity
Average Turnover Rate
60 days
--
120 days
--
5 years
--
Turnover Deviation
20 days
-100.00%
60 days
--
120 days
--
Peer Comparison
Food & Drug Retailing
RDGT
4.18 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Guardian Pharmacy Services Inc
GRDN
8.31 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bbb Foods Inc
TBBB
8.21 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Vital Farms Inc
VITL
7.98 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Albertsons Companies Inc
ACI
7.97 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Chefs' Warehouse Inc
CHEF
7.87 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of RDGT?
The TradingKey Stock Score provides a comprehensive assessment of RDGT based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of RDGT’s performance and outlook.
How do we generate the financial health score of RDGT?
To generate the financial health score of RDGT, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects RDGT's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of RDGT.
How do we generate the company valuation score of RDGT?
To generate the company valuation score of RDGT, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare RDGT’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of RDGT’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of RDGT.
How do we generate the earnings forecast score of RDGT?
To calculate the earnings forecast score of RDGT, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on RDGT’s future.
How do we generate the price momentum score of RDGT?
When generating the price momentum score for RDGT, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of RDGT’s prices. A higher score indicates a more stable short-term price trend for RDGT.
How do we generate the institutional confidence score of RDGT?
To generate the institutional confidence score of RDGT, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about RDGT’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of RDGT.
How do we generate the risk management score of RDGT?
To assess the risk management score of RDGT, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of RDGT’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of RDGT.
